• Company Information
  • About the Report
  • Documents
  • Outstanding Payments (MSME)
  • Complaints
  • Directors
  • Same Address Companies
  • Charges
  • Contact Details
  • Products & Services
  • Balance Sheet
  • Profit & Loss
  • Fund Raising
  • Shareholders & Investors
  • Board Meetings
  • Auditors

MEDIBOX PHARMA PRIVATE LIMITED

CIN: U72900DL2016PTC399490 As on: 2026-07-13

MEDIBOX PHARMA PRIVATE LIMITED (CIN: U72900DL2016PTC399490) is a Private company incorporated on 19 Aug 2016. It is classified as Non-government company and is registered at Registrar of Companies, Delhi. Its authorized share capital is Rs. 5000000.00 and its paid up capital is Rs. 3853030.00.

MEDIBOX PHARMA PRIVATE LIMITED's Annual General Meeting (AGM) was last held on 27 May 2024. and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 2024-03-31.MEDIBOX PHARMA PRIVATE LIMITED's NIC code is 7290 (which is part of its CIN). As per the NIC code, it is inolved in Other computer related activities [for example maintenance of websites of other firms/ creation of multimedia presentations for other firms etc.].

Directors of MEDIBOX PHARMA PRIVATE LIMITED are ARUSHI JAIN, UTTAM KUMAR PUKHARAJ JAIN, and GOPI NATH SAHU.

MEDIBOX PHARMA PRIVATE LIMITED's Corporate Identification Number (CIN) is U72900DL2016PTC399490 and its registration number is 399490. Users may contact MEDIBOX PHARMA PRIVATE LIMITED on its Email address - [email protected]. Registered address of MEDIBOX PHARMA PRIVATE LIMITED is 201, Mohan Place, LSC, C-Block, Saraswati Vihar , Delhi, Delhi, India - 110034.

Current status of MEDIBOX PHARMA PRIVATE LIMITED is - Active.

Basic Information

  • CIN
  • Name
  • Listed on Stock Exchange
  • Company Status
  • ROC
  • Registration Number
  • Company Category
  • Company Sub Category
  • Class of Company
  • Date of Incorporation
  • Age of Company
  • Activity
  • Number of Members

Annual Compliance Status

  • Date of Last Annual General Meeting
  • Date of Last Filed Balance Sheet

Key Numbers

  • Authorised Share Capital
  • Paid-up Share Capital
  • Total Assets
  • Revenue
  • Profit
  • Salaries & Other Employee Benefit Expenses
Want to see how this company compares within its industry or analyse broader market trends?
Explore Prime Research for Industry & Economic Insights

Previous Names

Previous CINs

ZaubaCorp's company report for MEDIBOX PHARMA includes audited balance sheets, profit & loss statements, charges, director history, shareholding and related-party transactions, compiled from official MCA filings — delivered as PDF and Excel.

Purchase Report

All companies in India are required to file various documents like financials, loan agreements, list of shareholders, details of directors, details of funding rounds and a lot more. These documents are credible and offer incredible insights about a company. However, understanding a company by viewing its documents is an extremely difficult and time consuming process.

Our reports are designed to save you significant time by surfacing key information easily and structuring it in a way that helps in your research.

Understanding the key findings and information in our reports can be crucial if you're a customer, vendor, investor, partner or even a potential employee of MEDIBOX PHARMA

Purchase full report of MEDIBOX PHARMA

Companies are required to file half yearly returns showing payments due to Micro & Small Enterprises that have been delayed more than 45 days. This information is crucial to understand if MEDIBOX PHARMA pays its vendors promptly. When seen over a period of time, this information could show if the company has slowed down in making payments to its small vendors. This information is available only if the company has filed its half yearly returns with the registrar of companies.

Filing Type As On Amount Due to MSME Current Liabilities Ratio to Current Liabilities Reasons for Delay

This section contains details of investor complaints or serious complaints filed with the registrar of companies. This information can surface potential red flags about a company.

Director Complaints
Date DIN Cessation Date Cessation Reason Complaint
Serious Complaints
Date Complaint Other Details
Investor Complaints & Other Complaints
Date Complaint Type Complaint Sub Type Particulars of Secutiries Period Complaint Other Details

Current Directors & Key Managerial Personnel of MEDIBOX PHARMA
DIN Director Name Designation Appointment Date
08012943 ARUSHI JAIN Director 2017-12-08
08066448 UTTAM KUMAR PUKHARAJ JAIN Director 2023-05-05
02877564 GOPI NATH SAHU Director 2024-03-05
Past Directors & Key Managerial Personnel of MEDIBOX PHARMA
DIN Director Name Designation Appointment Date Cessation
06758188 DHARAMVIR MALIK Director - 2023-12-18
06758188 DHARAMVIR MALIK Nominee Director - 2017-12-08
08012943 ARUSHI JAIN Nominee Director - 2017-12-08
08066448 UTTAM KUMAR PUKHARAJ JAIN Additional Director - 2023-05-20
00282404 RANDHIR MISHRA Director - 2016-12-12
01562249 VINOD NAHAR Additional Director - 2017-10-31
01562249 VINOD NAHAR Director - 2020-09-04
02877564 GOPI NATH SAHU Additional Director - 2024-05-26
03206187 BHAVIK KUMAR CEO(KMP) - 2021-09-13
03206187 BHAVIK KUMAR Director - 2017-12-08
03206187 BHAVIK KUMAR Whole-time director - 2021-09-13
Other Directorships of DHARAMVIR MALIK
Company Name CIN Designation Appointment Date Cessation
ACQUITTANCE CORPORATE CONSULTANTS LLP AAI-7608 Designated Partner - 2023-09-27
ACQUITTANCE CORPORATE CONSULTANTS LLP AAI-7608 Partner 2017-03-07 Ongoing
AKUMS LIFESCIENCES LIMITED U24231CH1996PLC017755 Additional Director - 2021-09-26
AKUMS LIFESCIENCES LIMITED U24231CH1996PLC017755 Director 2021-09-26 Ongoing
AKUMS HEALTHCARE LIMITED U24304DL2020PLC375098 Director - 2024-03-27
MALIK LIFESCIENCES PRIVATE LIMITED U63021DL2004PTC299408 Additional Director - 2015-05-25
AKUMENTIS HEALTHCARE LIMITED U72900DL2010PLC206414 Additional Director - 2015-04-30
AKUMENTIS HEALTHCARE LIMITED U72900DL2010PLC206414 Director - 2016-12-29
MAXCURE NUTRAVEDICS LIMITED U74899DL1994PLC057323 Additional Director - 2015-05-16
Other Directorships of ARUSHI JAIN
Company Name CIN Designation Appointment Date Cessation
UPADHRISH RESERCHEM LLP AAA-2807 Partner - 2019-04-01
DHANWANTRI VEDARESEARCH LLP AAU-0167 Designated Partner 2020-10-01 Ongoing
DHANWANTRI VEDARESEARCH LLP AAU-0167 Partner - 2024-03-29
HYGOSAP PHARMA PRIVATE LIMITED U24290DL2021PTC376044 Director 2021-01-22 Ongoing
AMERICAN REMEDIES LIFESCIENCES LIMITED U24299DL2020PLC371493 Director 2020-10-13 Ongoing
GERMAN REMEDIES LIFESCIENCES LIMITED U24304DL2020PLC371884 Director 2020-10-20 Ongoing
ALEAFIAA PHARMACEUTICALS PRIVATE LIMITED U74999MH2017PTC301818 Additional Director - 2018-12-26
ALEAFIAA PHARMACEUTICALS PRIVATE LIMITED U74999MH2017PTC301818 Director - 2021-03-30
Other Directorships of UTTAM KUMAR PUKHARAJ JAIN
Company Name CIN Designation Appointment Date Cessation
SILVER CROSS PHARMACEUTICALS LLP AAB-9190 Designated Partner 2022-04-01 Ongoing
SILVER CROSS PHARMACEUTICALS LLP AAB-9190 Partner - 2023-05-14
Arham Packsol LLP ABZ-0390 Partner - 2023-10-03
BIOMECH HEALTHCARE PRIVATE LIMITED U24299MP2019PTC050325 Director - 2020-11-21
CLONARTIS BIOTECH INDIA PRIVATE LIMITED U33203KA2019PTC125276 Director - 2019-10-10
FRONT SOURCE TECHNOLOGIES PRIVATE LIMITED U72900KA2021PTC151960 Director 2021-09-17 Ongoing
GOWMA NON LEATHER PRIVATE LIMITED U74999KA2017PTC100417 Additional Director - 2018-11-01
Other Directorships of RANDHIR MISHRA
Company Name CIN Designation Appointment Date Cessation
FASTWELL DEALCOM PRIVATE LIMITED U14100KA2010PTC132754 Additional Director - 2019-09-26
FASTWELL DEALCOM PRIVATE LIMITED U14100KA2010PTC132754 Director - 2021-02-16
FASTWELL DEALCOM PRIVATE LIMITED U14100KA2010PTC132754 Managing Director 2021-02-16 Ongoing
CAPALYST VENTURES PRIVATE LIMITED U74999KA2017PTC103548 Additional Director - 2019-09-30
CAPALYST VENTURES PRIVATE LIMITED U74999KA2017PTC103548 Director 2019-09-30 Ongoing
SGBS UNNATI FOUNDATION U80102KA2011NPL061201 Additional Director - 2016-09-30
SGBS UNNATI FOUNDATION U80102KA2011NPL061201 Director 2016-09-30 Ongoing
LEFOLI EDUCATION PRIVATE LIMITED U80901TG2010PTC069975 Director - 2020-11-02
METACOG INNOVATION PRIVATE LIMITED U80902KA2019PTC131025 Director 2019-12-25 Ongoing
PRACTICEO LEARNING SERVICES(I) PRIVATE LIMITED U80904TG2012PTC080908 Director - 2020-09-10
Other Directorships of VINOD NAHAR
Other Directorships of GOPI NATH SAHU
Company Name CIN Designation Appointment Date Cessation
CORWIS PHARMACEUTICALS LIMITED U24230DL2006PLC147642 Director 2009-12-15 Ongoing
PURE AND CURE HEALTHCARE PRIVATE LIMITED U24232DL2005PTC266385 Additional Director - 2015-11-21
PURE AND CURE HEALTHCARE PRIVATE LIMITED U24232DL2005PTC266385 Whole-time director 2015-11-21 Ongoing
MALIK LIFESCIENCES PRIVATE LIMITED U63021DL2004PTC299408 Additional Director - 2014-05-12
Other Directorships of BHAVIK KUMAR
Company Name CIN Designation Appointment Date Cessation
MEDIBOX TECHNOLOGIES LLP AAD-1311 Designated Partner 2014-12-31 Ongoing
SPLENDINA HEALTHCARE PRIVATE LIMITED U51397KA2010PTC055190 Director - 2013-01-01

CIN Company Name Company Address
U51909DL2017PTC325425 AVHA LIFESCIENCES PRIVATE LIMITED 201, 2nd FLOOR, MOHAN PLACE L.S.C, C-BLOCK, SARASWATI VIHAR , DELHI, Delhi, India - 110034
U24230DL2006PLC147642 CORWIS PHARMACEUTICALS LIMITED 201, MOHAN PLACE, LSC BLOCK-C, SARASWATI VIHAR , DELHI, Delhi, India - 110034
ACR-8719 SANGWAL ESSENTIALS LLP 202 Mohan Place LSC,C Block Saraswati Vihar,Delhi,North West Delhi,Delhi,India-110034
U46497DL2023PTC413542 QUALYMED PHARMA PRIVATE LIMITED 307, Plot No. 5, LSC, Mohan Place,Block-C, Saraswati Vihar, Pitampura,Delhi,North West Delhi,Delhi,110034-India
AAA-3138 AKUM IMPEX LLP 210, Mohan Place, LSC,C-Block, Saraswati Vihar Delhi, Delhi, India - 110034
U24233DL2007PLC165935 SUN BIOSCIENCES LIMITED 401, MOHAN PLACE, LSC BLOCK-C, SARASWATI VIHAR , DELHI, Delhi, India - 110034
U24232DL2009PLC186841 NICHOLAS HEALTHCARE LIMITED 401, LSC, C-BLOCK, MOHAN PLACE SARASWATI VIHAR , DELHI, Delhi, India - 110034
U51909DL1992PTC047353 VIVEKANANDA MARKETING PRIVATE LIMITED 202 MOHAN PLACE LSC C BLOCK SARASWATI VIHAR , DELHI, Delhi, India - 110034
U74999DL2007PTC159100 IPN MANUFACTURING ( INDIA ) PRIVATE LIMI TED 202, MOHAN PLACE, LSC, C-BLOCK SARASWATI VIHAR , DELHI, Delhi, India - 110034
U85195DL1987PLC194421 A.K. LABORATORIES LIMITED 210, MOHAN PLACE, LSC C-BLOCK, SARASWATI VIHAR , DELHI, Delhi, India - 110034
U99999DL1998PLC095297 AMAZING RESEARCH LABORATORIES LIMITED 109, Mohan Place, LSC, Block- C, Saraswati Vihar, , DELHI, Delhi, India - 110034
U64203DL2007PTC158306 RADIANT AIR SYSTEMS PRIVATE LIMITED 202, MOHAN PLACE, LSC C-BLOCK, SARASWATI VIHAR , NEW DELHI, Delhi, India - 110034
U72200DL2004PTC236007 TIMESINFO DATA SOLUTIONS PRIVATE LIMITED 202, MOHAN PLACE, LSC C-BLOCK, SARASWATI VIHAR , NEW DELHI, Delhi, India - 110034
U65929DL1996PTC079687 KANKAM FINANCE PRIVATE LIMITED 202MOHAN PLACE LSC C-BLOCK SARASWATI VIHAR , NEW DELHI, Delhi, India - 110034
U72300DL2008PTC186042 POOJA INFOSOLUTIONS PRIVATE LIMITED 202, MOHAN PLACE, LSC C-BLOCK, SARASWATI VIHAR , NEW DELHI, Delhi, India - 110034
U74140DL2006PTC154401 INDUS ADVISORS PRIVATE LIMITED 202, Mohan Place, LSC C-Block, Saraswati Vihar , New Delhi, Delhi, India - 110034
U24232DL2008PLC185686 PLENTEOUS PHARMACEUTICALS LIMITED 210, 2nd Floor, Mohan Place, LSC Block- C, Saraswati Vihar , Delhi, Delhi, India - 110034
U72900DL2010PLC206414 AKUMENTIS HEALTHCARE LIMITED 209, 2nd Floor, Mohan Place, LSC, C-Block, Saraswati Vihar, , Delhi, Delhi, India - 110034
U74899DL1995PLC069442 WELCURE FOODS AND NUTRITIONS LIMITED 307 PLOT NO-5 MOHAN PLACE-C BLOCK LSC SARASWATI VIHAR , DELHI, Delhi, India - 110034
U24200DL2021PLC375725 PARKE DAVIS HEALTHCARE LIMITED Unit No. 201, 2 Floor, LSC, Mohan Place Block-C, Saraswasti Vihar, Pitampura , Delhi, Delhi, India - 110034
U24100DL2022PTC393711 AKOME LIFECARE PRIVATE LIMITED Office No. 210, 2nd Floor, LSC, Mohan Place, Block-C,Saraswati Vihar,Pitampura , Delhi, Delhi, India - 110034
U24290DL2021PTC376044 HYGOSAP PHARMA PRIVATE LIMITED Unit No. 201, 2nd Floor, LSC, Mohan Place, BLK-C,Saraswati Vihar,Pitampura , DELHI, Delhi, India - 110034
U74899DL1994PLC057323 MAXCURE NUTRAVEDICS LIMITED Unit 101, Plot No.4, 1st Floor, Mohan Place LSC, Block-C, Saraswati Vihar , Delhi, Delhi, India - 110034
U65993DL1989PLC037353 DUKE HOLDINGS LIMITED 202,MOHAN PLACE L.S.C.C-BLOCK SARASWATI VIHAR , NEW DELHI, Delhi, India - 110034
U32109DL1986PLC026126 HIND COMPUTERS TELE COMMUNICATIONS AND ELECTRONICS LTD. 307, MOHAN PALACE, C BLOCK LSC, SARASWATI VIHAR , DELHI, Delhi, India - 110034
AAY-4693 METPRO CHEMICAL TREATMENTS LLP 202, Mohan Place LSC, B Block, Saraswati Vihar New Delhi, Delhi, India - 110034
U24233DL2013PLC262364 UNOSOURCE PHARMA LIMITED 305, THIRD FLOOR, C-BLOCK, PLOT NO. 5 MOHAN PLACE, SARASWATI VIHAR , DELHI, Delhi, India - 110034
U85300DL2019NPL355543 AKUMS FOUNDATION UNIT NO. 101, IST FLOOR, MOHAN PLACE LSC, BLK-C SARASWATI VIHAR , DELHI, Delhi, India - 110034
U24304DL2020PLC371884 GERMAN REMEDIES LIFESCIENCES LIMITED Unit No. 101, Plot No. 4, 1st Floor, Mohan Place LSC, BLK-C, Saraswati Vihar, , DELHI, Delhi, India - 110034

Charge ID Charge Creation Date Charge Modification Date Charge Closure Date Assets Under Charge Amount Charge Holder
100894203 2024-03-27 - - 70,000,000.00 The Hongkong and Shanghai Banking Corporation Limited

  • Email ID
  • Website
  • Address

This information shows products and services that contribute highest to the company's revenue. Analysing this over a period of time can show the evolution of the company in terms of the products and services it offers.

Financial Year Business Activity Code Business Activity Description Percentage of Turnover

Financial information is availalbe only if it has been filed by the company. If the company has not filed its returns, financials for the defaulting period will not be available.

2024-03-31 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31 2017-03-31 2016-03-31 2015-03-31 2014-03-31 2013-03-31 2012-03-31
Download Audited Financials
EQUITY AND LIABILITIES
   Shareholder's funds
      Share Capital
      Reserves & Surplus
      Money Received Against Share Warrants
   Share Application Money Pending Allotment
   Non-current Liabilities
      Long-term borrowings
      Deferred tax liabilities
      Other Long Term Liabilities
      Long Term Provisions
   Current Liabilities
      Short-term borrowings
      Trade Payables
      Other Current Liabilities
      Short Term Provisions
Total Equity and Liabilities
ASSETS
   Non-current Assets
      Fixed Assets
         Tangible Assets
         Intangible Assets
         Capital Work In Progress
         Intangible Assets Under Development
      Non-current Investments
      Deferred Tax Assets (net)
      Long-term Loans & Advances
      Other Non-current Assets
   Current Assets
      Current Investments
      Inventories
      Trade receivables
      Cash & Cash Equivalents
      Short-term Loans & Advances
      Other Current Assets
Total Assets

Financial information is availalbe only if it has been filed by the company. If the company has not filed its returns, financials for the defaulting period will not be available.

2024-03-31 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31 2017-03-31 2016-03-31 2015-03-31 2014-03-31 2013-03-31 2012-03-31
Download Audited Financials
REVENUE FROM OPERATIONS
   Domestic Turnover
      Sale of Goods Manufactured
      Sale of Goods Traded
      Sale of Supple of Services
   Export Turnover
      Sale of Goods Manufactured
      Sale of Goods Traded
      Sale or Supply of Services
   Other Income
Total Revenue From Operations
EXPENSES
   Cost of Materials Consumed
   Purchases of Stock in Trade
   Change in Inventories of
      Finished Goods
      Work in Progress
      Stock in Trade
   Employee benefit Expenses
   Managerial Remuneration
   Payment to Auditors
   Insurance Expenses
   Power & Fuel
   Finance Cost
   Depreciation & Amortization Expenses
   Other Expenses
Total Expenses
Profit before Exceptional Items, Extraordinary Items and Tax
   Exceptional Items
Profit before Extraordinary items and Tax
   Extraordinary Items
Profit before Tax
   Tax Expense
      Current Tax
      Deferred Tax
Profit/Loss after Tax from Continuing Operations
Profit/Loss after Tax from Discontinuing Operations
   Tax Expense of Discontinuing Operations
Total Profit/Loss
Earnings per Equity Share (EPS) before Extraordinary Items
   Basic
   Diluted
Earnings per Equity Share (EPS) after Extraordinary Items
   Basic
   Diluted

This section contains details of cash raised by allocation of equity or debentures. All types of fund raising acitivity is listed here including funding raised through Venture Capital. Attachments would contain further details of the fund raising activity including names of the investors. This information is available only if the company has raised funds through cash allotment of equity or debentures.

Date of Allotment Securities Alloted Terms Number of Securities Nominal Amount Premium Amount Due & Payable Premium Amount Paid Total Discount Amount to be Paid on Calls (Excluding Premium) Attachments

This section contains list of associate companies and joint ventures as per the most recently available annual returns. This information would not be available if the company has not filed annual returns at all or it does not have any subsidiaries or joint ventures.

Company Identifier Name Percentage of Shares Held

This section contains list of board resolutions reported by the company to the Registrar of Companies.

Date of Filing Date of Dispatch of Notice Date of Passing Resolution Section (Companies Act 2013) Section (Companies Act 1956) Subject Matter of Resolution Resolution Agreed By Resolution Type Additional Documents

This section contains auditors of a company over the years. This information is available if the company has filed their annual returns with the Registrar of Companies.

Financial Year Name of Auditor or Firm PAN of Auditor or Firm Membership Number / Registration Number Name of Auditor Signing Report Membership Number of Auditor Signing Report

Is this information out of date or is there a discrepancy with the information? Click on the Update Information button below and we will review the information.

Purchase our hand crafted financial report for $ 9.99